ClinicalTrials.gg
RecruitingNCT06779617Updated Nov 10, 2026

UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial

An interventional study of SEPSys and RESCUE in Sepsis and Patient Deterioration, sponsored by University of Maryland, Baltimore. Recruiting at 8 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Updated Nov 10, 2026Site recruiting status changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150,000
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 517 studies in Sepsis with a site in United States — 74 open to participants now, 99 under way, 3 of them phase 3. Sepsis · United States.

Planned enrollment
2nd of 310
150,000 · median 84
Started
2026
with 28 others
No phase
140 of 517
22 open now
Primary completion
2027-12
later than 64 of 98 live
Registered
471st of 517
by date

Among the 517 studies in Sepsis with a site in United States, this one is the 2nd largest by planned enrollment of the 310 interventional ones that give a count, is one of 29 that started in 2026, is one of 140 with no phase, reaches primary completion later than 64 of the 98 other live ones, and was the 471st registered.

Sepsis

2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.

Browse Sepsis studies →

Open to participants now

74 of the 517 studies in Sepsis with a site in United States are open now. Recruiting first, the newest first:

68 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 517 studies in Sepsis with a site in United States, or all of them as a file.
02

Study summary

This study is designed to test two new risk scores - one designed to predict a patient's four-hour risk of developing sepsis and one designed to predict a patient's four-hour risk of deterioration (cardiac arrest, death, unplanned ICU transfer, or rapid response team call). The goal of this study is to improve provider awareness of a patient's risk of these two negative outcomes by providing them with new risk scores. The primary outcome will be the time from when the risk score becomes elevated to when vital signs such as heart rate or blood pressure are measured, suggesting an increased awareness.

Read the detailed description

The University of Maryland Medical System is conducting a study designed to test two new risk scores - one designed to predict a patient's four-hour risk of developing sepsis and one designed to predict a patient's four-hour risk of deterioration (death, cardiac arrest, unplanned ICU transfer, or rapid response call). The goal of this study is to improve provider awareness of a patient's risk of these two negative outcomes, sepsis and deterioration, by providing them with new risk scores. To assess provider awareness of risk, this study will measure time from elevated risk score to measurement of vital signs, such as heart rate or blood pressure with the hope that increased awareness of risk will decrease time to vital sign measurement, indicating closer monitoring.

The first risk score, the RESCUE Score, produces a highly accurate 1-4 color-coded risk score where a 1 indicates that a patient has a low risk of having a deterioration event in the next four hours and a 4 indicates that the patient has a high risk of having a deterioration event in the next four hours. The second risk score, the SEPSys Score, produces a highly accurate 1-4 color coded risk score where 1 indicates that a patient has a low risk of developing sepsis in the next 4 hours and a 4 indicates that the patient has a high risk of developing sepsis in the next 4 hours. Both of these scores are predictive of events that may happen in the future but are not detective or diagnostic of events that are actively occurring.

In this study, hospitals will be randomized for the order in which they cross-over from the control arm (no risk score) to either having the SEPSys or RESCUE Score visible for their inpatients. After a few months with an individual risk score, the second risk score will be added. Thus, at the beginning of the study, no hospitals with have the new risk scores available, for a period in the middle of the study each hospital will have one risk score available, and by the end of the study all hospitals will have both risk scores available. Regardless of which risk scores are available, the clinicians will be free to recommend treatments and implement care plans using their own judgement. No procedures impacting patient care will be specified for this study.

03

Conditions studied

  • Sepsis
  • Patient Deterioration

Browse trials for

Keywords

  • Sepsis
  • Patient Deterioration
  • AI
  • Artificial Intelligence
  • Machine learning
  • Decision support
  • Clinical decision support
  • Early warning systems
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Hospital Unit Inclusion Criteria:

  • Units are part of a member hospital of the University of Maryland Medical System (UMMS)
  • Units treat inpatient patients
  • Units agree to participate in the study

General Encounter Inclusion Criteria:

  • Encounter is on a participating inpatient unit
  • Encounter is associated with a bedded patient in the hospital
  • Encounter is associated with an adult (at least 18 years of age at time of admission)

Additional SEPSys Encounter Inclusion Criteria:

  • Encounter has a SEPSys Score

Additional RESCUE Encounter Inclusion Criteria:

  • Encounter has a RESCUE Score

Exclusion Criteria:

Hospital Unit Exclusion Criteria:

  • Unit treats exclusively outpatients or is located in an outpatient setting
  • Unit treats primarily or exclusively pediatric patients (patients under the age of 18 years old)
  • Unit treats exclusively psychiatric patients

Additional SEPSys Encounter Exclusion Criteria:

  • Encounter is with OB for a normal delivery and the patient has yet to give birth. This encounter can become eligible once the patient has given birth.
  • Encounter is admitted with a diagnosis of sepsis
  • Sepsis was already diagnosed during the encounter

This encounter will have been eligible until the patient began showing clinical signs or symptoms of sepsis or received a diagnosis of sepsis. Once they have a diagnosis or clinical signs or symptoms of sepsis, their SEPSys Score will no longer be updated. Data will continue to be collected on time of laboratory orders and treatments.

Additional RESCUE Encounter Exclusion Criteria:

  • Encounter is admitted with a high RESCUE Score (RESCUE Score of 4)
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
150,000 participants (estimated)

Study arms

  • Experimental
    SEPSys

    Cluster has SEPSys Score only

    Device: SEPSys

  • Experimental
    RESCUE

    Cluster has RESCUE Score only

    Device: RESCUE

  • Experimental
    SEPSys+RESCUE

    Cluster has both SEPSys \& RESCUE Scores

    Device: SEPSys · Device: RESCUE

  • No intervention
    Baseline

    Cluster has neither SEPSys nor RESCUE

Interventions

  • DeviceSEPSys

    The SEPSys Score is a clinical decision support tool for predicting the risk of developing sepsis in the next 4 hours. The SEPSys Score produces a 1-4, color-coded risk, where 4 (red) is the highest risk and 1 (green) is the lowest risk.

  • DeviceRESCUE

    The RESCUE Score is a clinical decision support tool for predicting the risk of patient experiencing clinical deterioration (cardiac arrest, rapid response team call, death, or unplanned increase in care) in the next 4 hours. The RESCUE Score produces a 1-4, color-coded risk, where 4 (red) is the highest risk and 1 (green) is the lowest risk.

06

What researchers measure

Primary outcomes

  1. Time To Vital Sign Measurement

    Time to vital sign measurement after elevation of either the Sepsis Early Prediction System (SEPSys) or RESCUE Score. An elevated SEPSys or RESCUE Score is defined as a current SEPSys or RESCUE Score of 3 or 4 (highest risk) when the previous Score was a 1 (lowest risk) or 2.

    Time frame: From time of elevation of either the Sepsis Early Prediction System (SEPSys) or RESCUE Score to measurement of vital signs, assessed continually during the hospitalization (up to 24 hours after the elevation)).

Secondary outcomes

  1. Sepsis diagnosis

    The patient develops sepsis during the hospitalization following elevation of the SEPSys score. An elevated SEPSys or RESCUE Score is defined as a current SEPSys or RESCUE Score of 3 or 4 (highest risk) when the previous Score was a 1 (lowest risk) or 2.

    Time frame: Beginning at time of hospital admission and assessed continually until hospital discharge (average of 5 days).

  2. Time to sepsis-specific treatment

    Time from first elevated SEPSys Score to order/administration of sepsis indicated antibiotics or fluid bolus. An elevated SEPSys or RESCUE Score is defined as a current SEPSys or RESCUE Score of 3 or 4 (highest risk) when the previous Score was a 1 (lowest risk) or 2.

    Time frame: From time of elevation of the SEPSys Score to initiation of sepsis-specific antibiotics or fluid bolus, assessed continually during the hospitalization (up to 96 hours).

  3. Deterioration Events

    Binary outcome of deterioration event (cardiac arrest, death, rapid response team call, unplanned increase in level of care). An elevated SEPSys or RESCUE Score is defined as a current SEPSys or RESCUE Score of 3 or 4 (highest risk) when the previous Score was a 1 (lowest risk) or 2.

    Time frame: Beginning at time of hospital admission and assessed continually until hospital discharge (average of 5 days).

  4. Frequency of laboratory orders

    Frequency of laboratory orders or measurements after an elevated SEPSys or RESCUE Score. An elevated SEPSys or RESCUE Score is defined as a current SEPSys or RESCUE Score of 3 or 4 (highest risk) when the previous Score was a 1 (lowest risk) or 2.

    Time frame: From time of elevation of either the Sepsis Early Prediction System (SEPSys) or RESCUE Score to measurement of laboratory orders, assessed continually during the hospitalization (up to 24 hours).

07

Study locations

6 of 8 sites recruiting
  • University of Maryland Medical Center - Midtown
    Baltimore, Maryland 21201, United States
    Recruiting
  • University of Maryland Medical Center
    Baltimore, Maryland 21201, United States
    Recruiting
  • University of Maryland Upper Chesapeake Medical Center
    Bel Air, Maryland 21014, United States
    Not yet recruiting
  • University of Maryland Shore Medical Center
    Easton, Maryland 21601, United States
    Recruiting
  • University of Maryland Baltimore Washington Medical Center
    Glen Burnie, Maryland 21061, United States
    Recruiting
  • University of Maryland Charles Regional Medical Center
    La Plata, Maryland 20646, United States
    Recruiting
  • University of Maryland Capital Region Medical Center
    Largo, Maryland 20774, United States
    Recruiting
  • University of Maryland St. Joseph Medical Center
    Towson, Maryland 21204, United States
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Dec 2027, 22 months after the start.

Of 303 non-industry interventional studies with no phase under Sepsis, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 22 months is close to that.

Counting every sponsor, half of 326 studies reached it within 22 months; a quarter within 11 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 20, 2024
First posted
Jan 16, 2025
StartActual
Feb 1, 2026
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2028
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
4 sites changed recruiting status (4 now recruiting)
Show 4 sites
  • University of Maryland Medical Center · Baltimore, United StatesNot yet recruiting→Recruiting
  • University of Maryland Shore Medical Center · Easton, United StatesNot yet recruiting→Recruiting
  • University of Maryland Baltimore Washington Medical Center · Glen Burnie, United StatesNot yet recruiting→Recruiting
  • University of Maryland Charles Regional Medical Center · La Plata, United StatesNot yet recruiting→Recruiting
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    4 sites changed recruiting status (4 now recruiting)
    Show 4 sites
    • University of Maryland Medical Center · Baltimore, United StatesNot yet recruiting→Recruiting
    • University of Maryland Shore Medical Center · Easton, United StatesNot yet recruiting→Recruiting
    • University of Maryland Baltimore Washington Medical Center · Glen Burnie, United StatesNot yet recruiting→Recruiting
    • University of Maryland Charles Regional Medical Center · La Plata, United StatesNot yet recruiting→Recruiting
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06779617
Responsible party
Samuel Tisherman (Professor, Department of Surgery and the Program in Trauma, University of Maryland, Baltimore) — Principal investigator
First posted
Jan 16, 2025
Start date
Feb 1, 2026
Primary completion
Dec 2027 (estimated)
Completion
Dec 2028 (estimated)
Last update
Nov 10, 2026

Study contacts

Samuel A Tisherman, MD
Contact
stisherman@som.umaryland.edu
410-328-9114
Jason Heavner, MD
Contact
jason.heavner@umm.edu
410-553-8240

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion